William S. Ferguson

Osteosarcoma: The Addition of Muramyl Tripeptide to Chemotherapy Improves Overall Survival—A Report From the Children's Oncology Group

Paul A. Meyers, Cindy L. Schwartz, Mark Krailo et al. · Journal of Clinical Oncology · 2008 · 734 citations · Full text

Osteosarcoma: A Randomized, Prospective Trial of the Addition of Ifosfamide and/or Muramyl Tripeptide to Cisplatin, Doxorubicin, and High-Dose Methotrexate

Paul A. Meyers, Cindy L. Schwartz, Mark Krailo et al. · Journal of Clinical Oncology · 2005 · 711 citations · Full text

Phase II Trial of Trastuzumab in Combination With Cytotoxic Chemotherapy for Treatment of Metastatic Osteosarcoma With Human Epidermal Growth Factor Receptor 2 Overexpression: A Report From the Children's Oncology Group

David Ebb, Paul A. Meyers, Holcombe E. Grier et al. · Journal of Clinical Oncology · 2012 · 244 citations · Full text

Vinblastine and Methotrexate for Desmoid Fibromatosis in Children: Results of a Pediatric Oncology Group Phase II Trial

Stephen X. Skapek, William S. Ferguson, Linda Granowetter et al. · Journal of Clinical Oncology · 2007 · 192 citations

Treatment of metastatic osteosarcoma at diagnosis: a Pediatric Oncology Group Study.

Michael B. Harris, Peter W. Gieser, Allen M. Goorin et al. · Journal of Clinical Oncology · 1998 · 188 citations